Search research articles
Contact Us
Filters
Showing results (51-60 of 93) with videos related to
Page
of 10
Sort By:
American Journal of Blood Research
|
September 20, 2021
Accuracy of bone marrow histochemical TP53 expression compared to the detection of TP53 somatic mutations in patients with myelodysplastic syndromes harbouring a del5q cytogenetic abnormality
Esther N Oliva, Roberto Latagliata, Elena Sabattini, et al.
Journal of Clinical Medicine
|
November 9, 2024
Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study
Luana Fianchi, Matteo Bonanni, Alessandra Borchiellini, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
July 13, 2017
Treatment of Low-Blast Count AML using Hypomethylating Agents
Eleonora De Bellis, Luana Fianchi, Francesco Buccisano, et al.
Annals of Hematology
|
June 28, 2018
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia
Luca Maurillo, Francesco Buccisano, Alessandra Spagnoli, et al.
Blood Reviews
|
June 25, 2026
Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group
Francesco Marchesi, Corrado Girmenia, Enrico Maria Trecarichi, et al.
Journal of Hematology & Oncology
|
August 3, 2012
Outcome of therapy-related myeloid neoplasms treated with azacitidine
Luana Fianchi, Marianna Criscuolo, Monia Lunghi, et al.
Hematological Oncology
|
May 4, 2019
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors
Alessandro Andriani, Elena Elli, Giulio Trapè, et al.
American Journal of Hematology
|
July 19, 2016
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey
Enrico Maria Trecarichi, Livio Pagano, Bruno Martino, et al.
Annals of Hematology
|
April 20, 2016
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study
Francesco Buccisano, Anna Lina Piccioni, Carolina Nobile, et al.
British Journal of Haematology
|
July 30, 2022
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study
Vincenzo Marasco, Alfonso Piciocchi, Anna Candoni, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 93) with videos related to
Sort By:
Page
of 10
American Journal of Blood Research
|
September 20, 2021
Accuracy of bone marrow histochemical TP53 expression compared to the detection of TP53 somatic mutations in patients with myelodysplastic syndromes harbouring a del5q cytogenetic abnormality
Esther N Oliva, Roberto Latagliata, Elena Sabattini, et al.
Journal of Clinical Medicine
|
November 9, 2024
Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study
Luana Fianchi, Matteo Bonanni, Alessandra Borchiellini, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
July 13, 2017
Treatment of Low-Blast Count AML using Hypomethylating Agents
Eleonora De Bellis, Luana Fianchi, Francesco Buccisano, et al.
Annals of Hematology
|
June 28, 2018
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia
Luca Maurillo, Francesco Buccisano, Alessandra Spagnoli, et al.
Blood Reviews
|
June 25, 2026
Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group
Francesco Marchesi, Corrado Girmenia, Enrico Maria Trecarichi, et al.
Journal of Hematology & Oncology
|
August 3, 2012
Outcome of therapy-related myeloid neoplasms treated with azacitidine
Luana Fianchi, Marianna Criscuolo, Monia Lunghi, et al.
Hematological Oncology
|
May 4, 2019
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors
Alessandro Andriani, Elena Elli, Giulio Trapè, et al.
American Journal of Hematology
|
July 19, 2016
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey
Enrico Maria Trecarichi, Livio Pagano, Bruno Martino, et al.
Annals of Hematology
|
April 20, 2016
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study
Francesco Buccisano, Anna Lina Piccioni, Carolina Nobile, et al.
British Journal of Haematology
|
July 30, 2022
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study
Vincenzo Marasco, Alfonso Piciocchi, Anna Candoni, et al.
Page
of 10